Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival

Transplant Proc. 1992 Dec;24(6):2560-1.

Authors

T Eriksson¹, K Riesbeck, O Ostraat, H Ekberg, S Björkman

Affiliation

¹ Department of Surgery, Lund University, Malmö General Hospital, Sweden.

PMID: 1465866

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Animals
CD4-CD8 Ratio
Drug Administration Schedule
Flow Cytometry*
Graft Rejection / immunology
Graft Survival / drug effects*
Graft Survival / immunology
Heart Transplantation / immunology*
Immunophenotyping
Rats
Rats, Inbred WF
T-Lymphocyte Subsets / drug effects
T-Lymphocyte Subsets / immunology
Thalidomide / pharmacokinetics
Thalidomide / pharmacology*

Substances

Thalidomide